News

Bharat Parenterals announced that the 33th Annual General Meeting(AGM) of the company will be held on 19 September 2026.

Net profit of Bharat Parenterals declined 87.73% to Rs 1.01 crore in the quarter ended June 2026 as against Rs 8.23 crore during the previous quarter ended June 2025. Sales declined 19.19% to Rs 93.74 crore in the quarter ended June 2026 as against Rs 116.00 crore during the previous quarter ended June 2025. ParticularsQuarter EndedJun. 2026Jun. 2025% Var. Sales93.74116.00 -19 OPM %9.1111.88 - PBDT7.1911.15 -36 PBT-1.492.55 PL NP1.018.23 -88 Powered by Capital Market - Live News

Bharat Parenterals will hold a meeting of the Board of Directors of the Company on 5 August 2026.

Net Loss of Bharat Parenterals reported to Rs 4.80 crore in the quarter ended March 2026 as against net loss of Rs 4.73 crore during the previous quarter ended March 2025. Sales declined 4.19% to Rs 99.62 crore in the quarter ended March 2026 as against Rs 103.98 crore during the previous quarter ended March 2025.For the full year,net loss reported to Rs 8.19 crore in the year ended March 2026 as against net loss of Rs 12.63 crore during the previous year ended March 2025. Sales rose 1.48% to Rs 345.43 crore in the year ended March 2026 as against Rs 340.38 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales99.62103.98 -4 345.43340.38 1 OPM %-0.532.14 -4.580.79 - PBDT0.260.22 18 12.831.37 836 PBT-8.37-8.30 -1 -21.42-33.95 37 NP-4.80-4.73 -1 -8.19-12.63 35 Powered by Capital Market - Live News

Bharat Parenterals announced that the Board of Directors of the Company at its meeting held on 18 May 2026, has recommended a Final Dividend of Rs.1 per share (i.e.10%), subject to the approval of the shareholders.